Reportlinker Adds Malaria Patent Landscape 2009
NEW YORK, March 4 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
http://www.reportlinker.com/p0180100/Malaria-Patent-Landscape-2009.html
IP Overview presents a patent landscape analysis of the Malaria field.
Since the discovery of the parasite responsible for Malaria in 1880, this disease has been the subject of intensive research and development within the academic and industrial sectors with a first patent filed as early as 1907 describing a quinine based treatment. Despite the small market (~1 billion $) generated by the drugs currently commercialized, more than 3000 patents describing new ways to control malaria were filed since 1980 with a growing interest over the last decade.
Next to a very dynamic institutional research, some industrials are marking out their position expecting increased reputation, but also with the hope of public and private funding and growing solvability of currently infected countries. New collaborations are forming and companies emerge on very specific segments. With upcoming resistances, current challenges in controlling malaria consist in developing early rapid diagnostic tests, efficient and affordable preventive and curative drugs and vaccines but also in developing efficient insecticides and repellents. The R&D and patent strategy in this sector bring forth the interest of these three challenges.
In the current race for controlling malaria, this IP Overview provides you a comprehensive panorama of the intellectual property landscape and helps you:
- Position your company's R&D and IP Portfolio
- Identify key invent ors and key players involved in specific thematic
- Understand the collaboration networks and theirs dynamics
- Uncover trends and emerging segments
METHODOLOGY 9
INTRODUCTION 10
1. BRIEF OUTLINE OF THE MARKET 14
2. BRIEF OUTLINE OF THE PIPELINE 16
3. PROTECTION STRATEGIES 18
3.1. Evolution of patent filings over time 18
3.2. Priority filings 19
3.3. Extensions 23
3.4. Analysis of industrial filings over time 25
3.5. Study of the granting of US patents 25
3.6. Study of the granting of European patents 28
3.7. Study of the granting of Japanese patents 30
3.8. Evolution in the number of applicants 32
3.9. Breakdown by IPC codes 33
4. GENERAL ANALYSIS 37
4.1. Topology of patents in the sector 37
4.2. Analysis of the main applicants in the entire portfolio 38
4.3. Focus on the global strategy of the major industrial applicants 39
4.4. Collaborations 42
4.5. Citations between applicants 44
4.6. Most cited patents 46
5. FOCUS ON THE CLASSIFIED CHEMOTHERAPEUTIC COMPOUNDS 49
5.1. General analysis 49
5.1.1. Breakdown of patent filings over time 49
5.1.2. Focus on the main chemical classes 50
5.1.3. Focus on the other chemical classes 55
5.2. Applicants 58
5.2.1. Main applicants 58
5.2.2. Filings by main applicants over time 59
5.2.3. Topics protected for classified chemotherapeutic compounds 61
5.2.4. Topics protected for the other classified chemotherapeutic compounds 63
5.2.5. Emerging applicants 65
5.3. Inventors 66
5.3.1. Main inventors 66
5.3.2. Topics protected for classified chemotherapeutic compounds 67
5.3.3. Topics protected for other classified chemotherapeutic compounds 69
5.3.4. Research teams 71
5.3.5. Experts 73
5.3.6. Emerging inventors 74
6. FOCUS ON VACCINES 75
6.1. General analysis 75
6.1.1. Patent filings over time 75
6.1.2. Breakdown of patents by types of vaccines 75
6.2. Applicants 78
6.2.1. Main applicants 78
6.2.2. Topics protected 81
6.3. Inventors 83
6.3.1. Main inventors 83
6.3.2. Topics protected 85
6.3.3. Research teams 87
6.3.4. Experts 90
7. FOCUS ON DIAGNOSTIC 91
7.1. General analysis 91
7.1.1. Breakdown of patent filings over time 91
7.1.2. Breakdown of patents by diagnostic method 92
7.2. Applicants 95
7.2.1. Main applicants 95
7.2.2. Topics protected 97
7.2.3. Emerging applicants 99
7.3. Inventors 100
7.3.1. Main inventors 100
7.3.2. Topics protected 101
7.3.3. Research teams 103
7.3.4. Experts 105
7.3.5. Emerging inventors 105
8. FOCUS ON OTHER MALARIA PATENTS 107
8.1. General analysis 107
8.1.1. Breakdown of patent filings over time 107
8.2. Breakdown of other malaria patents 108
8.3. Applicants 111
8.3.1. Main applicants 111
8.3.2. Topics protected 113
8.4. Inventors 115
8.4.1. Main inventors 115
8.4.2. Topics protected 117
CONCLUSION 119
APPENDICES 122
NUMBER OF PATENT FILINGS BY APPLICANTS 123
NUMBER OF PATENT FILINGS OF COMPANIES PRESENT IN THE PIPELINE 131
To order this report:
Pharmaceutical Industry: Malaria Patent Landscape 2009
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)-652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article